Chikungunya medical therapy: Difference between revisions

Jump to navigation Jump to search
Line 41: Line 41:
* Persistent [[joint pain]] may benefit from use of [[NSAIDs]], [[corticosteroids]], or [[physiotherapy]].
* Persistent [[joint pain]] may benefit from use of [[NSAIDs]], [[corticosteroids]], or [[physiotherapy]].


===Other Measures==
===Antibiotic Therapy===
 
===Additional Measures===
* Heat may increase/worsen [[joint pain]] and is therefore best to avoid during acute stage.
* Heat may increase/worsen [[joint pain]] and is therefore best to avoid during acute stage.
* Mild forms of [[exercise]] and [[physiotherapy]] are recommended in recovering persons.
* Mild forms of [[exercise]] and [[physiotherapy]] are recommended in recovering persons.
Line 47: Line 49:
* Cold compresses may be suggested depending on the response.
* Cold compresses may be suggested depending on the response.
* Exposure to warm environments (morning and evening sun) may be suggested as the acute phase subsides.
* Exposure to warm environments (morning and evening sun) may be suggested as the acute phase subsides.
===Treatment of Complications===
==Chronic Treatment==


==References==
==References==

Revision as of 18:48, 17 June 2014

Chikungunya Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Chikungunya from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Chikungunya medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Chikungunya medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chikungunya medical therapy

CDC on Chikungunya medical therapy

Chikungunya medical therapy in the news

Blogs on Chikungunya medical therapy

Directions to Hospitals Treating Chikungunya

Risk calculators and risk factors for Chikungunya medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2], Alonso Alvarado, M.D. [3]

Overview

There is no specific antiviral therapy for chikungunya virus. The treatment of the disease is based on decreasing the symptoms.

Medical Therapy for the Acute Phase

The treatment for chikungunya infection is symptomatic and the initial therapy focuses on decrease the symptoms. It is important to evaluate for other serious conditions (such as dengue, malaria, or bacterial infections) and treat or manage appropriately.

Hydration

Assess hydration and hemodynamic status and provide proper rehydration therapy (preferably oral) instituted quickly. It is important to identify patients with severe dehydration, as this patients should be carefully observed and rapid rehydration therapy should be started.

Severe dehydration Mild or Moderate dehydration
Characterized by two of these signs:
  • Excessive sleepiness or lethargy
  • Sunken eyes
  • Poor fluid intake
  • Dry, parched tongue
  • Reduced skin turgor (very slow skin pinch taking more than 2 sec to retract)
Characterized by two of these signs:

Management of Symptoms

Antibiotic Therapy

Additional Measures

  • Heat may increase/worsen joint pain and is therefore best to avoid during acute stage.
  • Mild forms of exercise and physiotherapy are recommended in recovering persons.
  • Patients may be encouraged to walk, use their hands for eating, writing and regular isotonic exercises.
  • Cold compresses may be suggested depending on the response.
  • Exposure to warm environments (morning and evening sun) may be suggested as the acute phase subsides.

Treatment of Complications

Chronic Treatment

References